Clari Vest Asset Management LLC Amicus Therapeutics, Inc. Transaction History

Clari Vest Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$8.71 - $10.72 $425,378 - $523,543	-48,838 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$9.2 - $23.86 $26,679 - $69,194	-2,900 Reduced 5.61%	48,838 $482,000
Q4 2020 Feb 09, 2021	SELL	$13.47 - $24.89 $949,540 - $1.75 Million	-70,493 Reduced 57.67%	51,738 $1.19 Million
Q3 2020 Nov 09, 2020	SELL	$12.89 - $15.89 $72,003 - $88,761	-5,586 Reduced 4.37%	122,231 $1.73 Million
Q2 2020 Aug 12, 2020	BUY	$8.86 - $15.69 $264,098 - $467,687	29,808 Added 30.41%	127,817 $1.93 Million
Q1 2020 May 04, 2020	BUY	$6.63 - $11.16 $649,799 - $1.09 Million	98,009 New	98,009 $906,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.